Approved: First Biosimilar to Treat Anemia
The US Food and Drug Administration (FDA) has approved a new medication to treat anemia.
A Change in REMS Requirements
The US Food and Drug Administration (FDA) has lifted the Risk Evaluation and Mitigation Strategy (REMS) requirements for certain medications used to treat anemia.
An Extra Benefit for Sickle Cell Rx
A drug commonly used to treat sickle cell disease (SCD) may wind up helping patients in more ways than one.
FDA Green Lights Anemia Drug Omontys
U.S. Food and Drug Administration officials have approved Omontys ( peginesatide ), a drug administered through monthly injections to treat anemia in patients with chronic kidney disease.